Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825079 · ClinicalTrials.gov registry record · NA
Does Weightbearing Crutch Technology Impact Patient Compliance?
A NA study of Fracture Healing, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05825079: Completed NA study of Fracture Healing, sponsored by NYU Langone Health.
NCT05825079 is a NA study of Fracture Healing that has completed, run by NYU Langone Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05825079, a NA study of Fracture Healing, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine if weight-bearing crutch technology that delivers active feedback to patients during their treatment will impact patient compliance with physician instructions.
Primary Outcome
Average weight put on crutch measured using the Smart Crutch Tip.
Conditions Studied
Interventions
- BEHAVIORAL Weight-Bearing Feedback
- DEVICE Smart Crutch Tip
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2025-07-28 |
| Phase | NA |
What the finished NCT05825079 record still lists
NCT05825079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Fracture Healing appearing as the primary indexed condition, and to 2 interventions - of which Weight-Bearing Feedback is the first listed.
NCT05825079 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05825079 about?
NCT05825079 is a clinical study titled "Does Weightbearing Crutch Technology Impact Patient Compliance?". The goal of this study is to determine if weight-bearing crutch technology that delivers active feedback to patients during their treatment will impact patient compliance with physician instructions.
What is the current status of trial NCT05825079?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-06-09. Estimated completion is 2025-07-28.
What conditions does trial NCT05825079 study?
This clinical trial studies the following conditions: Fracture Healing.
What interventions are being tested in trial NCT05825079?
The interventions under investigation include: Weight-Bearing Feedback (BEHAVIORAL), Smart Crutch Tip (DEVICE).
Who is sponsoring clinical trial NCT05825079?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825079 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05825079's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI